Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1450245

Effect of Hypoxia-induced mIL15 Expression on Expansion and Memory Progenitor Stem-like TILs in vitro

Provisionally accepted
Zhen Sun Zhen Sun 1,2Aotian Xu Aotian Xu 2*Zhaojun Wu Zhaojun Wu 2Xiaohao Lan Xiaohao Lan 2*Ganchen Gao Ganchen Gao 2*Bin Guo Bin Guo 2*Zhongjie Yu Zhongjie Yu 2Lin Shao Lin Shao 2*Hao Wu Hao Wu 2*Min Lv Min Lv 2*Yongjie Wang Yongjie Wang 3*Yi Zhao Yi Zhao 2*Bin Wang Bin Wang 1,2,4*
  • 1 Department of Pathogenic Biology, College of Basic Medicine, Qingdao University, Qingdao, China
  • 2 Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
  • 3 Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
  • 4 Department of special medicine, School of basic medicine, Qingdao University, Qingdao, China

The final, formatted version of the article will be published soon.

    The adoptive cell transfer of tumor-infiltrating lymphocytes (TILs) has proven clinically beneficial in patients with non-small cell lung cancer refractory to checkpoint blockade immunotherapy, which has prompted interest in TIL-adoptive cell transfer. The transgenic expression of IL15 can promote the expansion, survival, and function of T cells ex vivo and in vivo and enhance their anti-tumor activity. The effect of expressing mIL15 regulated by hypoxia in the tumor microenvironment on the expansion, survival, and stem-like properties of TILs has not been explored.Methods: Using TILs expanded from the tumor tissues of lung cancer patients, TILs with or without mIL15 expression (TIL-mIL15 or UN-TIL) were generated by lentiviral transduction. To reflect the advantages of mTIL15, the cells were divided into groups with IL2 (TIL-mIL15+IL2) or without IL2 (TIL-mIL15-IL2). Results: Compared to UN-TIL cells, mIL15 expression had a similar capacity for promoting TIL proliferation and maintaining cell viability. Our experimental findings indicate that, compared to UN-TIL and TIL-mIL15+IL2 cells, the expression of mIL15 in TIL-mIL15-IL2 cells promoted the formation of stem-like TILs (CD8 + CD39 -CD69 -) and led to significant decreases in the proportion and absolute number of terminally differentiated TILs (CD8 + CD39 + CD69 + ). RNA-Seq data revealed that in TIL-mIL15-IL2 cells, the expression of genes related to T cell differentiation and effector function, including PRDM1, ID2, EOMES, IFNG, GZMB, and TNF, were significantly decreased, whereas the expression of the memory stem-like T cell marker TCF7 was significantly increased. Furthermore, compared to UN-TIL and TIL-mIL15+IL2 cells, TIL-mIL15-IL2 cells showed significantly lower expression levels of inhibitory receptors LAG3, TIGIT, and TIM3, which was consistent with the RNA-Seq results. Discussion: This study demonstrates the superior ex vivo 删除[孙振]: -删除[孙振]: -删除[孙振]: -删除[孙振]:2 persistence of TIL-mIL15-IL2 cells, which may serve as a novel treatment strategy for lung cancer patients.

    Keywords: lung cancer, Tumor-infiltrating lymphocytes, membrane-bound interleukin 15, expansion, adoptive cell transfer, Immunotherapy, Hypoxia regulation

    Received: 17 Jun 2024; Accepted: 01 Nov 2024.

    Copyright: © 2024 Sun, Xu, Wu, Lan, Gao, Guo, Yu, Shao, Wu, Lv, Wang, Zhao and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Aotian Xu, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Xiaohao Lan, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Ganchen Gao, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Bin Guo, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Lin Shao, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Hao Wu, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Min Lv, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Yongjie Wang, Department of Thoracic Surgery, The Affiliated Hospital of Qingdao University, Qingdao, China
    Yi Zhao, Qingdao Sino-Cell Biomedicine Co., Ltd., Qingdao, China
    Bin Wang, Department of Pathogenic Biology, College of Basic Medicine, Qingdao University, Qingdao, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.